In this experiment, we aimed to monitor the metabolic intermediates including de novo amino acids in A549 cells upon exposure to U-C13 glucose. We observed that A549 cells produce kinetically labelled
Introduction: Adjustable intragastric balloon (aIGB), as known as a novel minimally invasive therapy for obesity, provide a sustained alternative for weight loss. Weight loss is achieved by implanting
Objective: Endogenous subclinical hyperthyroidism (eSCH) is defined by subnormal serum thyroid-stimulating hormone (TSH) level. There is limited evidence of metabolic changes induced by eSCH. The aim